Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer

  • Technology appraisal guidance
  • TA389
  • Published: 

Do no do examples

Title Year published Impact Level
No results could be found